Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies
Folegatti PM., Flaxman A., Jenkin D., Makinson R., Kingham-Page L., Bellamy D., Ramos Lopez F., Sheridan J., Poulton I., Aboagye J., Tran N., Mitton C., Roberts R., Lawrie AM., Hill AVS., Ewer KJ., Gilbert S.
<jats:p>Heterologous prime-boost strategies are known to substantially increase immune responses in viral vectored vaccines. Here we report on safety and immunogenicity of the poxvirus Modified Vaccinia Ankara (MVA) vectored vaccine expressing four Mycobacterium avium subspecies paratuberculosis antigens as a single dose or as a booster vaccine following a simian adenovirus (ChAdOx2) prime. We demonstrate that a heterologous prime-boost schedule is well tolerated and induced T-cell immune responses.</jats:p>